A review concerning the breast cancer-related tumour microenvironment
Article in Critical Reviews in Oncology/Hematology (May 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab
Article in Journal of Clinical Oncology (March 2024)
An Open-Label Study of Subcutaneous CpG Oligodeoxynucleotide (PF03512676) in Combination with Trastuzumab in Patients with Metastatic HER2+ Breast Cancer.
Article in Cancer Control (January 2024)